Prospect Radar · 2026-10-14

Research candidates, NOT trade signals. Configuration: quiet name + first substantive touch by a graded author + no mechanics poison. Base rate: such touches precede a ±10% move ~1.5× more often than chance — direction unknown. These are names worth YOUR research today.

HROW — via @MMMTwealth↗ (grade A)

• crowd: 1 authors / 1 signals · 5d run -4.8% · no listed options
• thesis: Presents bull and conservative valuation cases implying substantial HROW upside.
• receipt: tweet ↗

HUBC — via @PrismDM↗ (grade A)

• crowd: 3 authors / 4 signals · 5d run +0.0% · no listed options
• thesis: Midday mover report gives exact gains, losses and prices for five stocks.
• receipt: tweet ↗

285A.T — via @SayNoToTrading↗ (grade A)

• crowd: 3 authors / 6 signals · 5d run +0.0% · no listed options
• thesis: Explicitly adds Kioxia while rejecting additions to three memory peers.
• receipt: tweet ↗

RSPD — via @MacroAlphaHQ↗ (grade A)

• crowd: 3 authors / 3 signals · 5d run +0.0% · no listed options
• thesis: Highlights consumer-stock underperformance and forecasts declining sector earnings amid cost pressure.
• receipt: tweet ↗

MDA.TO — via @KairosPraxis↗ (grade A)

• crowd: 2 authors / 2 signals · 5d run +0.0% · no listed options
• thesis: Bullish strategic-partnership thesis for MDA with European defense applications.
• receipt: tweet ↗

MKSI — via @ALEXEIMARTOV↗ (grade A)

• crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
• thesis: Discloses MKSI ownership and compares its upside torque with higher-quality peers.
• receipt: tweet ↗

SKYD — via @TylerHardt↗ (grade A)

• crowd: 5 authors / 5 signals · 5d run +0.0% · no listed options
• thesis: Bloomberg reports SKYD's new bonds underperformed the broad market by the most since the pandemic.
• receipt: tweet ↗

4194.T — via @MikeFritzell↗ (grade A)

• crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
• thesis: Discloses selling Visional shares over margin pressure and strong LinkedIn competition.
• receipt: tweet ↗

ZURA — via @bioinvestor24↗ (grade A)

• crowd: 5 authors / 8 signals · 5d run +0.0% · no listed options
• thesis: Predicts TL1A agents including ZURA's will displace more toxic IL-17 therapies.
• receipt: tweet ↗

PKSY — via @junkbondinvest↗ (grade A)

• crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
• thesis: Shows one PKSY deal drove investment-grade new-issue underperformance of 27 basis points.
• receipt: tweet ↗

HONA — via @ID_Research_↗ (grade A)

• crowd: 3 authors / 3 signals · 5d run +0.0% · no listed options
• thesis: Presents a long-term aerospace spin-off thesis after a 30% decline
• receipt: tweet ↗

Research candidates, NOT trade signals. Configuration: quiet name + first substantive touch by a graded author + no mechanics poison. Base rate: such touches precede a ±10% move ~1.5× more often than chance — direction unknown. These are names worth YOUR research today.

SPCXQ — via @BradMunchen↗ (grade A)

• crowd: 1 authors / 4 signals · 5d run +0.0% · no listed options
• thesis: Explicitly discloses an existing SpaceX short and gives five bearish reasons.
• receipt: tweet ↗

OOEN — via @gnoble79↗ (grade A)

• crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
• thesis: Discloses having shorted the named stock at 8 while expressing extreme bearishness.
• receipt: tweet ↗

EYPT — via @KampnerSam↗ (grade A, hot hand)

• crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
• thesis: Quantifies severe drawdowns across four eye-care pharmaceutical stocks.
• receipt: tweet ↗

MSGS — via @ThematicTrader↗ (grade A)

• crowd: 1 authors / 2 signals · 5d run -0.2% · no listed options
• thesis: Bullish valuation thesis expects the MSGS spin to narrow a large sum-of-parts discount.
• receipt: tweet ↗

EURUSD — via @AtlasShrug1↗ (grade A)

• crowd: 4 authors / 5 signals · 5d run +0.0% · no listed options
• thesis: Discloses closed NUAI calls, an ongoing euro short, and a hedged CCJ-versus-XME position amid a bearish regime view.
• receipt: tweet ↗

TTD — via @alphatrends↗ (grade A)

• crowd: 2 authors / 2 signals · 5d run +0.7% · no listed options
• thesis: TTD trades at $12 versus the CEO's $24.66 average cost on a six-million-share purchase.
• receipt: tweet ↗

BAESY — via @LOGOinvestor↗ (grade A)

• crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
• thesis: Argues defense stocks have bottomed and offer long-term value and stability.
• receipt: tweet ↗

MUB — via @ramahluwalia↗ (grade A, hot hand)

• crowd: 2 authors / 2 signals · 5d run +0.0% · no listed options
• thesis: Explicitly recommends buying rate-sensitive assets after a capitulatory selloff.
• receipt: tweet ↗

TIP — via @KrisAbdelmessih↗ (grade A)

• crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
• thesis: Explicitly states a new purchase of TIPS and promises details on the trade.
• receipt: tweet ↗

2408.TW — via @Leoskie_L↗ (grade A)

• crowd: 2 authors / 2 signals · 5d run +0.0% · no listed options
• thesis: Argues conventional DRAM makers may benefit more directly than HBM from memory scarcity and pricing.
• receipt: tweet ↗

COF — via @ramahluwalia↗ (grade A, hot hand)

• crowd: 2 authors / 2 signals · 5d run -0.8% · no listed options
• thesis: Explicitly recommends buying rate-sensitive assets after a capitulatory selloff.
• receipt: tweet ↗

SKDD — via @labubu_trader↗ (grade A)

• crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
• thesis: Names two inverse semiconductor instruments in reply to a position discussion.
• receipt: tweet ↗